Howard W. Robin Sells 19,998 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 19,998 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $0.78, for a total transaction of $15,598.44. Following the completion of the transaction, the chief executive officer now directly owns 919,799 […]

Related Keywords

Ohio ,United States ,Hong Kong ,Howardw Robin , ,First Citizens Bank Trust Co ,Jefferies Financial Group ,Nektar Therapeutics ,Goldman Sachs Group Inc ,Y Intercept Hong Kong Ltd ,Nektar Therapeutics Company Profile ,Get Free Report ,Employees Retirement System ,Citizens Bank ,Intercept Hong Kong Ltd ,Sachs Group ,Nektar Therapeutics Daily ,Nasdaq Nktr ,Nktr ,Medical ,64026810 ,Insider Trading ,Nsider Trades ,Stocks ,